Explore the closed system of the cardiovascular system where blood is contained within the heart and vessels. Learn about the total blood volume and its significance for overall health and function.

4 views • 21 slides

The evidence-based science and clinical management of Cardiovascular-Kidney-Metabolic Syndrome (CKM) in this comprehensive slide set. Learn about the pathophysiological interactions, multi-organ dysfunction, and adverse cardiovascular outcomes associated with CKM.

0 views • 14 slides

The increased risk of cardiovascular disease in people with HIV and specific strategies to treat it. This presentation discusses potential mechanisms, comorbidity gaps, and the impact of traditional risk factors. Explore the role of inflammation and immune dysfunction in atherosclerosis and vulnerab

0 views • 38 slides

This study explores how inflammation and cholesterol levels predict cardiovascular events among 13,970 statin-intolerant patients in the CLEAR Outcomes trial. Findings suggest residual inflammatory risk may be a stronger predictor than residual cholesterol risk for future events. The research analyz

0 views • 17 slides

The study compares the efficacy of ticagrelor monotherapy after less than 1 month of dual anti-platelet therapy (DAPT) to 12-month ticagrelor-based DAPT in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) with drug-eluting stent implantation. The aim is

1 views • 19 slides

Cardiovascular disease is a growing concern in individuals living with HIV, despite advancements in treatment. The REPRIEVE Trial sheds light on the importance of assessing cardiovascular risk and implementing primary prevention measures in this population. Dr. Grinspoon's financial disclosures and

0 views • 35 slides

This update covers key aspects of managing type 2 diabetes and addressing cardiovascular risks, including discussions on GLP-1 receptor agonists, patient safety concerns, evidence-based recommendations, and individualized therapy approaches. It also includes a patient case study highlighting the imp

3 views • 52 slides

This advanced cardiovascular life support algorithm provides step-by-step guidance in managing cardiac emergencies such as cardiac arrest, arrhythmias, and other life-threatening conditions. The algorithm includes a series of slides detailing important procedures and interventions to improve patient

5 views • 9 slides

The REPRIEVE trial focuses on developing a cardiovascular disease prevention strategy for individuals living with HIV. It addresses the increased risk of CVD in this population, even with good viral suppression. The study evaluates the use of pitavastatin, a statin with anti-inflammatory properties,

1 views • 33 slides

Explore the differences between pediatric and adult cardiovascular exams, highlighting key differences in disease patterns, examination approaches, and objectives. Learn about the importance of distinguishing between routine well-baby exams and evaluations of ill children, along with step-by-step gu

6 views • 24 slides

Explore the comprehensive agenda covering topics like the general structure of the circulatory system, blood circulation in the human body, risk factors for cardiovascular diseases, and physiotherapeutic approaches in cardiac rehabilitation. Gain insights into the anatomy of the heart, arteries, vei

6 views • 14 slides

The CLEAR Outcomes Trial investigated the effects of bempedoic acid, an ATP citrate lyase inhibitor, on cardiovascular outcomes in primary prevention patients. Results showed a reduction in cardiovascular events with bempedoic acid, particularly in patients intolerant to statins. Baseline characteri

0 views • 13 slides

The cardiovascular information systems (CVIS) market is experiencing a period of exciting growth and innovation. CVIS market is expected to reach a staggering $1.09 billion by 2032.

1 views • 9 slides

Cardiovascular disease (CVD) is a leading cause of maternal mortality in the US, with disparities in morbidity. Standardizing evaluation and triage is crucial. Preventability studies show a high potential for identifying at-risk cases. The CVD Toolkit aims to enhance awareness and readiness among he

1 views • 17 slides

Cardiac output, stroke volume, end-diastolic and end-systolic volumes play vital roles in cardiovascular function. Factors affecting cardiac output include physiological conditions and pathological states like hyperthyroidism and myocardial infarction. Venous return, controlled by mechanisms like Fr

0 views • 27 slides

Empagliflozin's impact on cardiovascular and renal events in heart failure with reduced ejection fraction was assessed in the EMPEROR-Reduced trial led by Milton Packer, MD, and Faiez Zannad, MD. The trial, enriched for patients with severe left ventricular dysfunction, randomized participants to em

2 views • 22 slides

Dive into the intricate details of cardiac electrical activity in this lecture led by Physiology Team 436. Explore topics like the cardiac conductive system, action potentials, refractory periods, excitation-contraction coupling, and the effects of autonomic stimulation on heart electrophysiology. D

0 views • 29 slides

Exploring the immediate and long-term effects of exercise on the cardiovascular system reveals the remarkable adaptations and responses the body undergoes. From short-term increases in heart rate and blood pressure to long-lasting changes in cardiac output, exercise plays a crucial role in enhancing

0 views • 13 slides

Explore the intricate details of coronary circulation, including arterial supply, branches of coronary arteries, and areas of distribution. Dr. Abeer Al-Masri, an Associate Professor and Cardiovascular Physiologist at the Faculty of Medicine, KSU, provides valuable insights on the topic, covering th

1 views • 30 slides

Exploring the intricate workings of the cardiovascular system, this comprehensive guide covers the heart, blood vessels, circulation, and the composition of blood. Learn about the structure and functions of the heart chambers, blood vessels, and the vital role of blood in maintaining circulation. De

2 views • 16 slides

The impact of diet on the cardiovascular system is significant, with a high intake of LDL leading to clogged arteries and increased risk of Coronary Heart Disease. Regular exercise brings about positive changes in the cardiovascular system, enhancing heart function and oxygen delivery. Immediate ben

0 views • 7 slides

In a secondary analysis of the CANTOS study, researchers evaluated the impact of residual inflammatory risk and residual cholesterol risk in a large cohort of atherosclerosis patients already receiving lipid-lowering therapy. Results showed the relative contributions of inflammation and cholesterol

0 views • 11 slides

Your heart is the engine of life. This small yet mighty organ is central to your overall health. From blood pressure to gastrointestinal health, every aspect of your health relies on the condition of your heart. So put your cardiovascular health firs

1 views • 4 slides

Statin intolerance is the inability to tolerate at least two statins, with symptoms like muscle aches. Despite the benefits of statins in reducing cardiovascular risk, some patients experience side effects leading to intolerance. Understanding the definition, prevalence, and management of statin int

0 views • 43 slides

This report discusses the morphologic and physiologic connections in continuous blood pressure waveforms and their association with incident cardiovascular events. The study aims to assess if changes in arterial elasticity contribute to predicting CVD events and explores additional measures derived

0 views • 30 slides

Cardiovascular disease remains a significant contributor to maternal mortality in the UK, with maternal deaths from cardiac issues outnumbering those from other direct causes, except thrombosis. The prevalence of cardiovascular risk factors in pregnant women, combined with a lack of consideration fo

0 views • 22 slides

The data report examines the prevalence of cardiovascular diseases in adult End-Stage Renal Disease (ESRD) patients in 2016 by treatment modality and age. It includes information on various cardiovascular conditions such as atrial fibrillation, acute myocardial infarction, coronary artery disease, a

2 views • 25 slides

This informative content discusses the normal physiological changes of the cardiovascular system in pregnancy, symptoms and signs of cardiovascular disease, the impact of pregnancy on cardiovascular health, and the management of cardiovascular issues during pregnancy, labor, and the postpartum perio

0 views • 28 slides

Explore the world of cardiovascular drugs, including antihypertensive, antianginal, heart failure, antiarrhythmic, diuretic, antithrombotic, and antihyperlipidemic medications. Dive into the mechanisms of action, clinical indications, and adverse effects of these drugs, gaining valuable insights int

0 views • 39 slides

Cardiovascular effects of older glucose-lowering therapies and the history of cardiovascular outcome trials are discussed in this educational slide module. It outlines the timeline of treatment options from the discovery of insulin to the introduction of various medications. Evidence regarding the c

0 views • 29 slides

Individuals with type 2 diabetes have an increased risk of cardiovascular events compared to those without the condition. Research indicates that certain GLP-1 receptor agonists have shown promising results in reducing cardiovascular events in diabetic patients with specific HbA1c levels. However, t

0 views • 69 slides

The ATLAS-ACS 2 study investigated the efficacy and safety of rivaroxaban in ACS patients post-index event. The primary endpoints included cardiovascular death, MI, and stroke, with significant reductions seen with rivaroxaban compared to placebo. Stent thrombosis was also reduced with rivaroxaban t

0 views • 10 slides

GripTrack is a portable grip strength monitoring device designed to track cardiovascular and musculoskeletal health in the elderly population. It aims to provide an accurate early warning system by assessing grip strength, which can indicate cognitive decline, cardiovascular health, and frailty synd

0 views • 14 slides

This presentation discusses the significant cardiovascular effects of air pollution, particularly on vulnerable populations such as older adults, women, and Latinos. It highlights the environmental factors contributing to cardiovascular health disparities and emphasizes the nursing implications for

0 views • 13 slides

Explore the intricate workings of the cardiovascular system, encompassing the heart, blood vessels, and blood circulation. Learn the anatomy, physiology, and function of this vital system, including the roles of arteries, veins, capillaries, and red and blue blood. Understand how the cardiovascular

0 views • 23 slides

Understanding the prevalence and causes of cardiovascular diseases in patients with End-Stage Renal Disease (ESRD) is crucial for effective management. This report analyzes data from 2011-2013, focusing on the causes of death in ESRD patients, prevalence of cardiovascular diseases by treatment modal

0 views • 18 slides

Cardiologists in 2019 must address the significant cardiovascular risks associated with diabetes mellitus. Dr. Keith C. Ferdinand highlights the increased rates of heart disease, stroke, and heart failure in patients with diabetes. Despite advancements, cardiovascular risk management remains subopti

0 views • 10 slides

The Cardiovascular Disease Prevention Fellowship Programme by Health Innovation Network offers a comprehensive 7-month program for healthcare professionals to enhance their skills in cardiovascular disease prevention. The program includes clinical webinars, improvement collaborative sessions, and qu

0 views • 14 slides

The role of cardiovascular clinicians in managing cardiovascular risk in patients with type 2 diabetes is evolving, with a growing emphasis on collaboration with multidisciplinary teams. Recognizing the potential benefits of certain diabetes medications on cardiovascular outcomes, clinicians are urg

0 views • 25 slides

PCSK9 inhibitors are a novel class of medications that help lower LDL cholesterol levels, reducing the risk of cardiovascular events. This article covers their mechanism of action, patient groups benefiting from them, efficacy in LDL-C lowering, and safety considerations. Learn how PCSK9 inhibitors

0 views • 8 slides